Xylo Technologies Ltd (XYLO)
NASDAQ: XYLO · Real-Time Price · USD
3.810
-0.980 (-20.46%)
Feb 21, 2025, 4:00 PM EST - Market closed
Xylo Technologies Market Cap
Xylo Technologies has a market cap or net worth of $2.79 million as of February 21, 2025. Its market cap has decreased by -46.36% in one year.
Market Cap
2.79M
Enterprise Value
-227.81K
1-Year Change
-46.36%
Ranking
Category
Stock Price
3.81
Market Cap Chart
Since August 5, 2015, Xylo Technologies's market cap has decreased from $29.00M to $2.79M, a decrease of -90.38%. That is a compound annual growth rate of -21.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 3.50M | 34.62% |
| Dec 31, 2024 | 2.60M | -51.85% |
| Dec 29, 2023 | 5.40M | -29.87% |
| Dec 30, 2022 | 7.70M | -51.27% |
| Dec 31, 2021 | 15.80M | 28.46% |
| Dec 31, 2020 | 12.30M | 86.36% |
| Dec 31, 2019 | 6.60M | 164.00% |
| Dec 31, 2018 | 2.50M | 108.33% |
| Dec 29, 2017 | 1.20M | -66.67% |
| Dec 30, 2016 | 3.60M | -79.07% |
| Dec 31, 2015 | 17.20M | -40.69% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 786.51B |
| UnitedHealth Group | 466.90B |
| Johnson & Johnson | 381.02B |
| Novo Nordisk | 370.06B |
| AbbVie | 349.49B |
| Abbott Laboratories | 228.56B |
| AstraZeneca | 228.16B |
| Merck & Co. | 218.79B |